Bioregenx (BRGX) Cash from Financing Activities (2022 - 2026)
Bioregenx's quarterly Cash from Financing Activities came in at -$50206.0 in Q1 2026, down 382.05% year-on-year from $17800.1 in Q1 2025, and down 13.73% quarter-over-quarter from -$44143.0 in Q4 2025.
Bioregenx has reported Cash from Financing Activities for 5 years, with the latest figure at -$50206.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities fell 382.05% year-over-year to -$50206.0; the trailing twelve-month figure through Mar 2026 stood at -$6693.0 (down 104.49% YoY), and the FY2025 full-year result was $33098.0, down 92.51% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$50206.0, down from -$44143.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $513370.0 in Q4 2023, with the low at -$50206.0 in Q1 2026.
- Average Cash from Financing Activities over 5 years is $104393.9, with a median of $39118.5 recorded in 2022.
- Year-over-year, Cash from Financing Activities surged 14571.91% in 2023 and plunged 535.7% in 2025.
- Tracing BRGX's Cash from Financing Activities over 5 years: stood at $3499.0 in 2022, then surged by 14571.91% to $513370.0 in 2023, then sank by 101.35% to -$6944.0 in 2024, then sank by 535.7% to -$44143.0 in 2025, then retreated by 13.73% to -$50206.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$50206.0 (Q1 2026), -$44143.0 (Q4 2025), and $70833.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | -178.05 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | -70.02 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | -137.18 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | -112.85 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | -93.16 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 13.46 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -8.42 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -10.67 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 2.39 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | -50,206.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50,206.00 |
| Mar 31, 2026 | -50,206.00 |
| Dec 31, 2025 | -44,143.00 |
| Dec 31, 2025 | -44,143.00 |
| Sep 30, 2025 | 70,833.00 |
| Sep 30, 2025 | 70,833.00 |
| Jun 30, 2025 | 16,823.00 |
| Jun 30, 2025 | 16,823.00 |
| Mar 31, 2025 | -10,415.00 |
| Mar 31, 2025 | -10,415.00 |
| Dec 31, 2024 | -6,944.00 |
| Dec 31, 2024 | -6,944.00 |
| Sep 30, 2024 | 46,442.00 |
| Sep 30, 2024 | 46,442.00 |
| Jun 30, 2024 | 120,059.00 |
| Jun 30, 2024 | 120,059.00 |
| Mar 31, 2024 | 282,562.00 |
| Mar 31, 2024 | 282,562.00 |
| Dec 31, 2023 | 513,370.00 |
| Dec 31, 2023 | 513,370.00 |
| Sep 30, 2023 | 116,108.00 |
| Sep 30, 2023 | 116,108.00 |
| Jun 30, 2023 | 410,105.00 |
| Jun 30, 2023 | 410,105.00 |
| Mar 31, 2023 | 164,739.00 |
| Mar 31, 2023 | 164,739.00 |
| Dec 31, 2022 | 3,499.00 |
| Dec 31, 2022 | 3,499.00 |
| Sep 30, 2022 | 5,676.00 |
| Sep 30, 2022 | 5,676.00 |
| Jun 30, 2022 | 31,795.00 |
| Jun 30, 2022 | 31,795.00 |